Assessment of chromogranin A using two-site immunoassay. Selection of a monoclonal antibody pair unaffected by human chromogranin A processing.
Degorce
F
F
CIS Biointernational, Division In Vitro Technologies, Bagnols-sur-Cèze, France.
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor / Q000032:analysis / Q000097:blood; D001774:Blood Chemical Analysis; D053379:Chromogranin A; D002864:Chromogranins / Q000032:analysis* / Q000097:blood / Q000276:immunology* / Q000378:metabolism; D000939:Epitopes / Q000737:chemistry; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007150:Immunohistochemistry / Q000379:methods; D015592:Immunoradiometric Assay; D018358:Neuroendocrine Tumors / Q000737:chemistry / Q000175:diagnosis; D011499:Protein Processing, Post-Translational
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; C506150:CHGA protein, human; D053379:Chromogranin A; D002864:Chromogranins; D000939:Epitopes